These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 16007245)

  • 1. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease.
    Moscona A
    J Clin Invest; 2005 Jul; 115(7):1688-98. PubMed ID: 16007245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo.
    Xu R; Palmer SG; Porotto M; Palermo LM; Niewiesk S; Wilson IA; Moscona A
    mBio; 2013 Oct; 4(5):e00803-13. PubMed ID: 24149514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of human parainfluenza virus type 3 with the host cell surface.
    Moscona A
    Pediatr Infect Dis J; 1997 Oct; 16(10):917-24. PubMed ID: 9380464
    [No Abstract]   [Full Text] [Related]  

  • 4. Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue.
    Palmer SG; Porotto M; Palermo LM; Cunha LF; Greengard O; Moscona A
    mBio; 2012; 3(3):. PubMed ID: 22669629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site.
    Porotto M; Fornabaio M; Greengard O; Murrell MT; Kellogg GE; Moscona A
    J Virol; 2006 Feb; 80(3):1204-13. PubMed ID: 16414997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
    Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).
    Murrell M; Porotto M; Weber T; Greengard O; Moscona A
    J Virol; 2003 Jan; 77(1):309-17. PubMed ID: 12477836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of amino acids at stalk/head interface of human parainfluenza virus type 3 hemagglutinin-neuraminidase protein in the membrane fusion process.
    Jiang J; Wen H; Chi M; Liu Y; Liu J; Cao Z; Zhao L; Song Y; Liu N; Chi L; Wang Z
    Virus Genes; 2018 Jun; 54(3):333-342. PubMed ID: 29516315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hijacking the Fusion Complex of Human Parainfluenza Virus as an Antiviral Strategy.
    Marcink TC; Yariv E; Rybkina K; Más V; Bovier FT; des Georges A; Greninger AL; Alabi CA; Porotto M; Ben-Tal N; Moscona A
    mBio; 2020 Feb; 11(1):. PubMed ID: 32047132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.
    Porotto M; Greengard O; Poltoratskaia N; Horga MA; Moscona A
    J Virol; 2001 Aug; 75(16):7481-8. PubMed ID: 11462020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on functions of N-carbohydrate chains in human parainfluenza virus type 3 hemagglutinin-neuraminidase protein].
    Chu FL; Wen HL; Hou GH; Lin B; Zhang WQ; Song YY; Ren GJ; Sun CX; Li ZM; Wang ZY
    Bing Du Xue Bao; 2013 Sep; 29(5):500-8. PubMed ID: 24386838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II.
    Palermo LM; Porotto M; Greengard O; Moscona A
    J Virol; 2007 Sep; 81(17):9152-61. PubMed ID: 17567695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection.
    Palmer SG; DeVito I; Jenkins SG; Niewiesk S; Porotto M; Moscona A
    J Virol; 2014 Nov; 88(22):13495-502. PubMed ID: 25210187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation.
    Iketani S; Shean RC; Ferren M; Makhsous N; Aquino DB; des Georges A; Rima B; Mathieu C; Porotto M; Moscona A; Greninger AL
    mBio; 2018 Jul; 9(4):. PubMed ID: 29970463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3.
    Ah-Tye C; Schwartz S; Huberman K; Carlin E; Moscona A
    Microb Pathog; 1999 Nov; 27(5):329-36. PubMed ID: 10545258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo.
    Prince GA; Ottolini MG; Moscona A
    J Virol; 2001 Dec; 75(24):12446-51. PubMed ID: 11711635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.
    Porotto M; Fornabaio M; Kellogg GE; Moscona A
    J Virol; 2007 Apr; 81(7):3216-28. PubMed ID: 17229690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein.
    Porotto M; Murrell M; Greengard O; Doctor L; Moscona A
    J Virol; 2005 Feb; 79(4):2383-92. PubMed ID: 15681439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
    Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
    Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human parainfluenza virus fusion complex glycoproteins imaged in action on authentic viral surfaces.
    Marcink TC; Wang T; des Georges A; Porotto M; Moscona A
    PLoS Pathog; 2020 Sep; 16(9):e1008883. PubMed ID: 32956394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.